We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+4.53%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$8.5B
AUM Growth
+$1.06B
Cap. Flow
+$740M
Cap. Flow %
8.7%
Top 10 Hldgs %
20.59%
Holding
2,213
New
217
Increased
1,136
Reduced
703
Closed
106

Sector Composition

Rank Sector Weight
1 Technology 5.27%
2 Financials 4.79%
3 Healthcare 4%
4 Industrials 3.92%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAT icon
2076
Nordic American Tanker
NAT
$1.36B
$28K ﹤0.01%
+11,230
New +$46.5K
TURN
2077
DELISTED
180 Degree Capital
TURN
$25K ﹤0.01%
4,308
EXK
2078
Endeavour Silver
EXK
$2.9B
$24K ﹤0.01%
10,010
EPE
2079
DELISTED
EP Energy Corporation
EPE
$24K ﹤0.01%
10,000
IDXG
2080
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$23K ﹤0.01%
+2,260
New +$27.3K
CLNE icon
2081
Clean Energy Fuels
CLNE
$355M
$22K ﹤0.01%
10,610
-14,310
-57% -$31.6K
CRNT icon
2082
Ceragon Networks
CRNT
$198M
$21K ﹤0.01%
10,735
ATHX
2083
DELISTED
Athersys, Inc. Common Stock
ATHX
$21K ﹤0.01%
472
-88
-16% -$4.26K
HMY icon
2084
Harmony Gold Mining
HMY
$12B
$20K ﹤0.01%
+10,796
New +$19.3K
ASXC
2085
DELISTED
Asensus Surgical, Inc.
ASXC
$19K ﹤0.01%
771
-364
-32% -$11.2K
ORKA
2086
Oruka Therapeutics
ORKA
$6.03B
$14K ﹤0.01%
48
EGY icon
2087
Vaalco Energy
EGY
$602M
$12K ﹤0.01%
16,855
-3,000
-15% -$2.35K
SDR
2088
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$10K ﹤0.01%
+11,624
New +$13.8K
PGH
2089
DELISTED
Pengrowth Energy Corporation
PGH
$9K ﹤0.01%
11,518
-5,149
-31% -$4.78K
CRDF icon
2090
Cardiff Oncology
CRDF
$75.5M
$7K ﹤0.01%
297
-13
-4% -$576
NVCN
2091
DELISTED
Neovasc Inc.
NVCN
0
ADNT icon
2092
Adient
ADNT
$1.44B
-2,418
Closed -$203K
ASUR icon
2093
Asure Software
ASUR
$248M
-10,900
Closed -$135K
ATHM icon
2094
Autohome
ATHM
$2.64B
-4,108
Closed -$247K
BHF icon
2095
Brighthouse Financial
BHF
$3.47B
-4,300
Closed -$261K
BKH icon
2096
Black Hills Corp
BKH
$5.61B
-6,438
Closed -$443K
BKT icon
2097
BlackRock Income Trust
BKT
$341M
-8,929
Closed -$168K
BPMC
2098
DELISTED
Blueprint Medicines
BPMC
-3,500
Closed -$244K
CIF
2099
DELISTED
MFS Intermediate High Income Fund
CIF
-26,860
Closed -$79K
CLW icon
2100
Clearwater Paper
CLW
$377M
-4,145
Closed -$204K

Similar funds

Cambridge Investment Research Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Cambridge Investment Research Advisors held 2,213 positions worth $8.5B, up 14% from $7.44B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $740M of net new capital in Q4 2017, opening 217 new positions and adding to 1,136 existing holdings. Its largest new stake was State Street SPDR Bloomberg Investment Grade Floating Rate ETF: 445,407 shares worth $13.7M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 5.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Real Estate ETF, an estimated $12.9M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2017 buy was State Street SPDR Bloomberg Investment Grade Floating Rate ETF: 445,407 shares worth $13.7M.
  • Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q4 2017, an estimated $25.4M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2017 reduction was iShares US Real Estate ETF, cutting an estimated $12.9M.
  • Cambridge Investment Research Advisors fully exited ProShares Short Russell2000 in Q4 2017, selling an estimated $5.38M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $8.5B portfolio in Q4 2017.
  • Cambridge Investment Research Advisors opened 217 new positions and closed 106 in Q4 2017.
  • Cambridge Investment Research Advisors's portfolio value rose 14% quarter-over-quarter to $8.5B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2017, filed 22 Feb 2018.